The life science investment company KD Ventures announces that John Öhd is moving from his role as
Head of Research to become senior advisor. Going forward, he will concentrate his operational involvement on his role as CEO of Modus Therapeutics, one of KD Ventures’ portfolio companies. This is stated in a press release.
